ArticleCancer cell international2022

miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.

Hu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.